DICER1 and hematologic disorder: In conclusion, our systematic review and meta-analysis revealed that low Dicer expression level was a significant predictor of poor prognosis in cancer patients especially in ovarian cancer, hematological malignancy, ENT tumor, and neuroblastoma.